---
figid: PMC4356243__nihms667914f5
figtitle: Advances in therapeutic development for spinal muscular atrophy
organisms:
- Homo sapiens
- Mus musculus
- Danio rerio
- H4N4 subtype
pmcid: PMC4356243
filename: nihms667914f5.jpg
figlink: /pmc/articles/PMC4356243/figure/F5/
number: F5
caption: 'Simplified version of intracellular MEK/ERK and AKT/CREB signaling pathways
  that affect SMN transcription, including the upstream regulators (NMDA, EGF, FGF,
  PDGF and BDNF). Activation of spinal cord NMDA receptors or inhibition of ERK by
  U0126 activates the AKT pathway leading to increased SMN2 transcription [,]. Activation
  of AKT triggers autophosphorylation of SRPK followed by its nuclear import and consequent
  phosphorylation of SR proteins that regulate alternative splicing []. Binding sites
  of transcription factors within SMN2 promoter are shown. In the inset for SMN2 pre-mRNA,
  exonic (coding) and intronic (non-coding) regions are indicated by boxes and lines,
  respectively. Two major SMN2 splice isoforms are shown at the bottom.EGFR: EGF receptor;
  FGFR: FGF receptor; NMDAR: NMDA receptor; PDGFR: PDGF receptor.'
papertitle: Advances in therapeutic development for spinal muscular atrophy.
reftext: Matthew D Howell, et al. Future Med Chem. ;6(9):1081-1099.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9336366
figid_alias: PMC4356243__F5
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
redirect_from: /figures/PMC4356243__F5
ndex: 68ea3385-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4356243__nihms667914f5.html
  '@type': Dataset
  description: 'Simplified version of intracellular MEK/ERK and AKT/CREB signaling
    pathways that affect SMN transcription, including the upstream regulators (NMDA,
    EGF, FGF, PDGF and BDNF). Activation of spinal cord NMDA receptors or inhibition
    of ERK by U0126 activates the AKT pathway leading to increased SMN2 transcription
    [,]. Activation of AKT triggers autophosphorylation of SRPK followed by its nuclear
    import and consequent phosphorylation of SR proteins that regulate alternative
    splicing []. Binding sites of transcription factors within SMN2 promoter are shown.
    In the inset for SMN2 pre-mRNA, exonic (coding) and intronic (non-coding) regions
    are indicated by boxes and lines, respectively. Two major SMN2 splice isoforms
    are shown at the bottom.EGFR: EGF receptor; FGFR: FGF receptor; NMDAR: NMDA receptor;
    PDGFR: PDGF receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - BDNF
  - BDNF-AS
  - EGF
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - EGFR
  - PDGFRB
  - PDGFRA
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - CAMK2G
  - RALA
  - RALB
  - GDF1
  - RNH1
  - PPP1R13L
  - SHC3
  - MAPK9
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - HSPA1A
  - HSPA4
  - MICE
  - SMN1
  - ELK1
  - KCNH4
  - KCNH8
  - SMN2
  - SRF
  - BTG3
  - ERVK-9
  - ERVK-11
  - ERVK-19
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - TCF3
  - DBT
  - MAN2C1
  - Bdnf
  - Egf
  - Grin1
  - Egfr
  - Pdgfrb
  - Grb2
  - ras
  - Hras
  - Kras
  - Rem1
  - Camk2a
  - Camk2b
  - Rala
  - Shc3
  - Akt1
  - Mdk
  - Ephb2
  - Mapk1
  - Hspa1b
  - Casp14
  - Ighmbp2
  - Elk1
  - Grm7
  - Srf
  - Btg3
  - Creb1
  - Tcf3
  - Rr149356
  - bdnf
  - egf
  - celsr1a
  - egfra
  - grb2b
  - rab1ab
  - hsp70.3
  - hspa8l
  - hsp70l
  - hsp70.1
  - elk1
  - srfa
  - U0126
  - Cancer
  - Noonan syndrome
---
